Last Updated on October 6, 2024 by The Health Master
Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium Tablets 3mg/0.03mg/0.451 mg and Levomefolate Calcium Tablets 0.451 mg) to the patient (consumer/user) level due to out of specification (OOS) test results at the 12-month stability time point.
Specifically, one lot (L200183) tested low for ascorbic acid (an inactive ingredient) and high for a known impurity.
To date, Lupin has received no reports of adverse events related to either recalled batches.
Regardless, Lupin is recalling these two batches because if there were a significant reduction in the amount of inactive content (ascorbic acid), this could potentially impact the effectiveness of the product, which could potentially result in an unexpected pregnancy.
Tydemy is estrogen/progestin oral contraceptive (COC) indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Tydemy is packaged in 28’s blister. One such blister was then packed in a pouch along with one printed sleeve, one pack insert (with day label) and one oxygen absorber (Stabilox) sachet. The three pouches were packed in one carton.
The lots were distributed nationwide in the US to wholesalers, drug chains, mail order pharmacies, and supermarkets.
The recalled lots are included in the table below:
Product | Lot No | Expiry | NDC(s) | UPC | Distribution Dates |
---|---|---|---|---|---|
TydemyTM | L200183 | Jan. 2024 | 68180-904-71 (1 Blister of 28 tablets each) 68180-904-73 (3 Blister of 28 tablets each) | 368180904731 | June 2022 to May 2023 |
L201560 | Sep. 2024 |
Lupin is notifying its wholesalers, distributors, drug chains, mail order pharmacies, and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product lots.
Patients taking Tydemy are advised to continue taking their medication and immediately contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment.
Wholesalers, distributors, and retailers that have Tydemy that is being recalled should discontinue distribution of the recalled product lots immediately.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (USFDA).
Drug recall: Sun Pharma, Alembic recall these drugs due to this reason
Drug recall: Dronabinol Capsules, Ziprasidone HCL Capsules recalled due to this reason
Drug recall: Typhoid vaccine recalled due to this reason
Drug recall: Pediatric Drops recalled due to this reason
Drug recall: 24,194 Prefilled Syringes of generic medication recalled due to this reason
USFDA concludes inspection at Solara with Zero observations: Tamil Nadu
India became “Aatmanirbhar: in 38 APIs: HM
Pharma Industry seeks faster export of Cough Syrups to Counter China’s Growing Dominance
CDSCO initiates training for Medical Device Officers to implement MDR 2017
Pharma Industry’s heavy reliance on Chinese Bulk Drug imports sparks concerns
USFDA issues warning letter to Intas Pharmaceuticals
Tax Dept uncovers Rs 6 Crore Tax Evasion in Pharma Companies: Uttrakhand
Gujarat FDCA takes stringent actions against Non-Compliant Pharma Companies
Major Crackdown: Rs 2 Crore-worth counterfeit drugs seized in Kolkata
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: